Related Experiment Video
Updated: Jun 21, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
[Chron's disease and cancer]
Rosario Fornaro1, Marco Frascio, Andrea Denegri
1Università degli Studi di Genova, Dipartimento di Discipline Chirurgiche e Metodologie Integrate, Genova. rfornaro@unige.it
Patients with Crohn's disease (CD) face increased risks for gastrointestinal and blood cancers. Early diagnosis, disease severity, smoking, and family history are key factors for colorectal cancer in CD patients.
Area of Science:
- Gastroenterology and Oncology
- Epidemiology of Chronic Diseases
Context:
- Crohn's disease (CD) patients exhibit elevated risks for various cancers compared to the general population.
- Identifying specific risk factors within the CD population is crucial for targeted cancer prevention and management strategies.
Purpose:
- To review and synthesize current evidence on cancer risk factors in patients diagnosed with Crohn's disease.
- To identify patient subgroups within the CD population who are at higher risk for developing specific types of cancer.
Summary:
- Patients with Crohn's disease have a significantly higher risk of colorectal cancer (CRC), particularly colon cancer, with risk factors including early-onset disease, longer duration, inflammation severity, smoking, family history, and immunosuppressive therapy.
- An increased risk for small bowel cancer and lymphoma is also noted in CD patients, though the role of immunosuppressive therapies requires further investigation.
- The study highlights that individuals with extensive colonic disease diagnosed at a young age are prime candidates for regular colonoscopic surveillance due to their heightened cancer risk.
Impact:
- Informs clinical practice by identifying high-risk CD patients who would benefit from enhanced surveillance protocols.
- Contributes to a better understanding of the complex interplay between Crohn's disease, its treatments, and cancer development.
- Provides a foundation for developing personalized risk-assessment tools and preventative measures for cancer in Crohn's disease patients.
Related Concept Videos
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Circadian Rhythms and Gene Regulation
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Positive Regulator Molecules
Psychoneuroimmunology: Diabetes and Cancer

